Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2941
-
2942
Office characteristics and RW adoption.
Published 2025“…The number of workers with LTSA-MD nominally decreased from fiscal 2019 to fiscal year 2020, with no significant difference. …”
-
2943
Identification of novel pathogenic mutations in <i>ATP6V0A4</i> associated with distal renal tubular acidosis and analysis of wild-type expression in glomerular disease
Published 2025“…If untreated, it can result in a significant electrolyte imbalance and progressive chronic kidney disease (CKD). …”
-
2944
-
2945
-
2946
Assessment of the relationship between adiposity, Sirtuin 1, and miR-30a-5p in a mixed-ancestry population in Bellville South, Cape Town.
Published 2025“…</p><p dir="ltr"><b>Study Results</b>: A total of 150 females and 150 males were selected for this study with an average age of 50 years. miR-30a-5p expression was significantly higher in overweight and obese participants compared to normal-weight individuals. …”
-
2947
-
2948
-
2949
Table 1_Genetic variants in the vitamin D pathway genes are predictors of the risk of diabetic kidney disease in Central Asian Kazakhstani cohort with type 2 diabetes.docx
Published 2025“…</p>Results<p>The CYP27A1 rs17470271 T/T genotype was significantly associated with a reduced risk of DKD under the recessive model (AOR = 0.32, 95% CI: 0.11–0.93). …”
-
2950
-
2951
-
2952
Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl...
Published 2025“…Beginning from day 28, when the solid tumors are of ~100mm<sup>3</sup> size, control and experimental mice were administered with drugs every other day for 18 days (total duration 46 days); on day 46, the mice were sacrificed and blood, vital organs and tumors were harvested for further analysis (b) Administration of STZ increased fasting blood sugar in mice: In order to establish hyperglycaemic state, mice were administered with low-dose STZ as detailed in methods section and blood sugar content determined using Morepen glucose monitoring strips. The data showed a significant increase in fasting blood glucose (FBG) beginning from day 6. …”
-
2953
-
2954
-
2955
-
2956
-
2957
-
2958
Experimental Investigation of the Impact of Mixed Wettability on Pore-Scale Fluid Displacement: A Microfluidic Study
Published 2024“…To address this limitation, a novel approach was employed that combined photolithography and molecular vapor deposition of perfluorodecyltrichlorosilane to precisely and selectively modify wettability within specific pore regions, achieving a mixed wettability distribution correlated with pore size for the first time. …”
-
2959
Experimental Investigation of the Impact of Mixed Wettability on Pore-Scale Fluid Displacement: A Microfluidic Study
Published 2024“…To address this limitation, a novel approach was employed that combined photolithography and molecular vapor deposition of perfluorodecyltrichlorosilane to precisely and selectively modify wettability within specific pore regions, achieving a mixed wettability distribution correlated with pore size for the first time. …”
-
2960
Table 1_LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity.docx
Published 2025“…We previously developed a live attenuated auxotrophic vaccine candidate, PAO1 ΔmurI, which conferred protection in murine infection models but exhibited significant reactogenicity when administered intranasally. …”